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Background: The World Health Organization (WHO) recommend the tailoring of a brief intervention (BI)
programme of research to ensure that it is both culturally and contextually appropriate for the country and the
environment in which it is being tested. The majority of BI research has been conducted with non-opioid
dependent participants. The current study developed a tailored BI for illicit drug use and alcohol use to a
methadone maintained opioid dependent polydrug using cohort of patients.
Methods: Focus groups with staff and one-to-one qualitative interviews with patients guided the tailoring of all
intervention materials for use in a subsequent cluster randomised controlled trial (RCT). This was done to make
them contextually appropriate to an opioid dependent cohort and culturally appropriate to Ireland. Thematic
analyses were utilised.
Results: The BI was modified to ensure its compatibility with the culture of an Irish drug using population, with
elements of motivational interviewing (MI) and personalised feedback incorporated. Example scripts of a screening
and BI were included, as was an algorithm to facilitate clinicians during a session. Modifications to the ‘Substance
Use Risk’ cards included weighting the severity of the problems, writing the language in the first person to
personalise the feedback and including tick boxes so as to further highlight the relevant risk factors for individual
patients. Photographs of key risk factors were included to display pictorially risks for illiterate or semi-literate
patients. Examples of the interaction of particular substances with methadone were of particular importance to this
group. Modifications of the ‘Pros and Cons of Substance Use/Reasons to Quit or Cut Down’ included additional
categories such as addiction, crime and money that were salient to this cohort. The manual was used to
standardise training across trial sites.
Conclusion: The research team was faithful to WHO recommendations to tailor BI programmes that are culturally
and contextually appropriate to the treatment cohort and clinical environment. Outcome data from the cluster RCT
have demonstrated that the tailored intervention was effective.
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The World Health Organization (WHO) recommends a
brief intervention (BI) as an intervention to address
patients’ problematic substance use [1]. This is achieved
through a two-step process. Firstly, the substance to be
targeted in the BI is identified using the valid and
reliable [2, 3] “Alcohol, Smoking and Substance Involve-
ment Screening Test” (ASSIST). Secondly, the clinician
delivers a BI for the most problematic substance, deter-
mined by the ASSIST. This involves helping patients to
identify substance use problems, understand the risks
involved and motivate a reduction or abstinence from
substance use as appropriate [1, 2, 4]. BIs are under-
pinned by a theoretical framework drawing primarily on;
i) principles of the Stages of Change model [5] identify-
ing patients’ level of motivation to change, and ii) Miller
and Rollnicks’ motivational interviewing (MI) eliciting
change talk and moving patients through the stages of
change [6], incorporating the FRAMES technique
(Feedback, Responsibility, Advice, Menu of Options,
Empathy, Self-efficacy).
The association between BIs and reduced alcohol con-
sumption has been depicted in numerous studies [7–10].
The effectiveness of screening and BI on illicit drug use
was examined with a sample of over seven hundred
patients recruited from primary care settings in Australia,
Brazil, India and the United States. After receiving a BI,
82.8 % of the sample attempted to reduce their illicit drug
use, with 60.2 % succeeding in maintaining this reduction
at 3 month follow-up [11]. To date, the impact of BIs on a
variety of illicit substances has been examined and shown
to be effective in relation to amphetamines [12], benzodi-
azepines [13], cannabis [14–16], cocaine [17, 18], and
illicit substances in general [2, 11, 19].
However, the majority of studies of the effectiveness of
BIs have been completed with non-opioid dependent
patient cohorts who represent members of the general
public attending primary care services, A&E departments
or community mental health services. A single previous
study, conducted by the current authors, has found
evidence for the effectiveness of a WHO BI, within com-
munity methadone clinics [20]. At 3 month follow-up
opioid dependent patients significantly reduced their
alcohol consumption as a result of receiving a BI. Existing
evidence, including our previous work, demonstrates the
effectiveness of BIs in reducing alcohol consumption.
Following on from this, a cluster randomised controlled
trial (RCT) was designed to examine the effectiveness of
BIs for illicit drugs and alcohol in Irish methadone
maintenance clinics. Results of the cluster RCT have been
published elsewhere [21].
Organisational culture and climate can have a
profound influence on organisational functioning and
effectiveness [22], and this in turn may influence thesuccessful outcome of implementing an intervention
according to the Quality Implementation Framework
[23]. It has also been recognised that interventions have
‘core components’ (the essential and indispensible
elements of the intervention) and an ‘adaptable
periphery’ (adaptable elements and structures related to
the intervention and organisation in which it is being
implemented) [24]. In recent years, the WHO have
advised that it is important to tailor BI programmes to
the population at hand and to consider the context and
culture of the service in which programmes will be
delivered [11]. The UK Medical Research Council
Framework for Developing Complex Interventions
suggests specific phases to the development of health
service interventions, such as, for example, systematic-
ally developing core components of the intervention
[25]. Integrating qualitative research in the design of a
complex intervention can contribute to optimising the
robustness of intervention materials [26] and has been
utilised within a number of complex interventions in the
pre-trial phase of the design [27–29]. A recent study
examining a brief motivational intervention for heavy
alcohol use in dental practice settings conducted web-
surveys and informal interviews with practitioners in the
design of intervention materials that were used in a
subsequent trial [30]. Qualitative focus groups were used
in recent studies designing a risk reduction intervention
for injecting drug users [31] and tailoring the treatment
of depression in older adults [32]. Qualitative research,
as well as providing important insights into processes of
change, is a good way to involve users by allowing for a
wider range of views to be canvassed and systematically
incorporated into the intervention [25].
The degree to which an intervention can be adapted,
tailored, and refined to meet local needs is a core
component of implementation [24]. Therefore, the
purpose of this paper is to describe the development and
the process of tailoring of a screening linked BI, through
qualitative methods. Intervention materials guided the
standardised training of clinicians across all trial sites for
the subsequent RCT.
Methods
The methods of this research are reported utilising the
consolidated criteria for reporting qualitative studies
(COREQ) [33].
Design
Focus groups (FGs) with clinical staff (n = 15) and one-to-
one interviews with patients (n = 10) were utilised. FGs
were chosen as the format best suited for the clinical staff
as participants could build on each other’s ideas, through
facilitated discussion in a group setting [34]. Also, FGs
were chosen for pragmatic reasons to minimise disruption
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teams once, thus reducing researchers’ time on the clinical
floors. A one-to-one format was chosen for the patients in
order to provide privacy and confidentiality. A semi-
structured interview guide was utilised in both formats of
qualitative inquiry. It employed open-ended questions
grouped around particular themes of interest to the re-
search question but also allowed participants the freedom
to discuss what was important or pertinent to them,
encouraging a free flow of conversation [35]. All patient
and clinician participants were provided with copies of the
draft intervention manual and material.
The Research Ethics Committee of the Drug Treat-
ment Centre Board approved this study.
Participants
Patient participants were selected using purposive sam-
pling, which is designed to identify specific groups of
people who possess characteristics relevant to the
phenomenon being studied [36]. Patients were opioid
dependent methadone maintained polydrug-misusing
patients, not attending any of the study sites to avoid
contamination. Patients were recruited through a forum
representing service users of addiction services. They
were approached by the patient organisation and then
introduced to the researcher (LW) once they agreed to
take part.
Clinician participants were chosen to represent the
clinical teams (multidisciplinary teams comprising
doctors, nurses, counsellors, outreach workers and phar-
macists) that had already been randomly selected to the
intervention arm of the cluster RCT. Clinicians were in-
vited to participate in a focus group after a presentation
of the research was made to the multidisciplinary team.
A total of ten semi-structured interviews occurred
with patients (10 in total) and two FGs with clinical staff
(15 in total). All participants that were approached
agreed to take part in the research.
Settings
The FGs with clinical staff took place in two large
Addiction Treatment Centres in Dublin, Ireland.
Approximately 90 % of all Irish persons on methadone
programmes are resident in Dublin and receive their
treatment there. The semi-structured interviews with
patients took place in a neutral setting with an organisa-
tion that hosts a service users’ forum for patients attend-
ing for Addiction Treatment in the North Inner City
of Dublin, Ireland. The facilitators of the focus groups
are academics and not clinicians themselves and were
not working in the services in which the qualitative
enquiry was undertaken. Only researchers and partici-
pants were present in the room during the FGs and
interviews.Procedures
All participants were provided with a participant infor-
mation sheet about the research including the members
of the research team and were given an opportunity to
raise any questions. Confidentiality was assured. All
participants signed a consent form. Both the FGs and
semi-structured interviews were tape-recorded and took
place between December 2012 and February 2013. On
average the FGs lasted 45 min and the semi-structured
interviews lasted 35 min. Authors (CD and LW) facili-
tated the FGs and interviews respectively. Both authors
were experienced in conducting qualitative research with
PhD and MSc qualifications respectively. Both were
working in the Department of Public Health and Pri-
mary Care, TCD in academic roles. Participants were
not provided with incentives to take part and were not
known to the authors conducting data collection. Partic-
ipants were told where the authors conducting the data
collection were working. Both clinicians and patients
were presented with a draft of the intervention manual
and all related draft materials for comment. The inter-
vention manual included a description and overview of
the main components of the ASSIST screening tool and
brief interventions such as motivational interviewing. A
step-by-step guide was included with resources to be
employed during a BI such as example pros and cons to
change of substance use behaviour. This was to be used
during the intervention by the clinician, not the patient.
Draft materials provided to participants included
examples of pros and cons for changing substance use
behaviour, take home material and readiness to change
rulers. There was some cross over between questions
asked within the FGs and interviews, with both stake-
holder groups asking questions that related to the
substance risk cards, the pros and cons of alcohol and
illicit drug use, and take home materials (see Additional
file 1 for sample FG and patient interview guides
respectively). These guides were pilot tested before use.
Field notes were made after the FGs and interviews took
place. Data collection continued until saturation was
reached. This is where no new ideas or themes emerge
during data collection.
Data analysis
The recordings of both FGs and all semi-structured
interviews were transcribed verbatim. To enhance rigour,
a summary of the main points was given at the end of
both FGs and interviews whereby participants were
asked if it was an accurate portrayal of what had been
discussed. This form of ‘member check’ allows for par-
ticipants to confirm or correct any errors in the topics
discussed [37]. Transcripts were not returned to partici-
pants. Two authors (CD & LW) independently analysed
the data and no software package was utilised. Each
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coding was applied, with a focus on experiential claims
and concerns [38].
Thematic analysis was chosen as the type of analysis
that would be undertaken as the aim of the preparatory
phase of the trial was to gather feedback from clinicians
and patients on drafted intervention materials with a
view to making changes to materials ahead of the train-
ing and start of the trial. Themes were not predeter-
mined in advance but rather they emerged from the
data. Patterns in the data were then clustered into a the-
matic structure. Thematic analysis was utilised to iden-
tify and categorise major themes, sub-theme concepts
and categories [39]. A thematic analysis was chosen as
the qualitative analytical method due to its realist and
constructionist perspective [40]. Thematic analysis is a
flexible and useful research tool, which provides a rich
and detailed, yet complex, account of the data [41]. The-
matic analysis involves the search for and identification
of common threads that extend across an entire inter-
view or set of interviews [42]. The themes were then
reviewed and refined to ensure they formed a coherent
pattern of major and sub-themes and were recoded if
necessary. Any differences in interpretation by the re-
searchers were resolved through discussion. An inter-
rater reliability of Cohen’s Kappa of 0.85 demonstrated a
high level of agreement between the two raters. This
form of multiple coding can enhance the rigour of quali-
tative analysis [43]. In reporting the results, the identities
of the participants were anonymised by providing them
with a pseudonym. For clarity in the quotes participants
who were patients were referred to as ‘Mary, patient’
and participants who were members of the clinical team
are referred to as ‘Sean, clinician’.
Results
The results will focus on the tailored elements of the
BI that were modified based on feedback from clini-
cians and patients through focus groups and inter-
views. (See Additional file 2 for copy of the tailored
BI manual).
Structure & components of a BI manual
The WHO describes the ASSIST and a BI across two
manuals; in the current study both elements were in-
corporated into one manual. Balanced by the neces-
sity of having enough information the decision to
streamline the manual was taken because of the
research team’s tacit knowledge of the busy, resource
constrained clinical environment within which the cli-
nicians work.
Participants suggested changes to the style of the man-
ual. For example, the research team had included a sin-
gle page ‘step by step’ algorithm guide to a BI to bedisplayed on treatment room walls. Participants in gen-
eral found the drafted algorithm helpful; they did suggest
alterations to its presentation, which were incorporated
into the final version. An algorithm was developed for
the tailored manual which incorporated the ASSIST and
the BI together diagrammatically with the use of timing
guidelines, the ‘5 A’s’ (Ask, Advise, Assess, Assist, and
Arrange) and colour coding for the ASSIST.
Peter, clinician: I also really like the algorithm but I
think it needs to be descending, that would make it
much easier to read. And maybe if you put the timings
beside it, to give us an idea of how long we are meant
to be spending on each section.
A sample script of a screening and BI session, reflect-
ive of a session between a clinician and a patient within
an Addiction Treatment Centre, was developed. For the
purposes of training, the sample script, the role-play and
the algorithm were synergised so that they reflected one
another for clarity purposes in training.
Patricia, clinician: The example script is very helpful…
You could nearly hear a session happening.Substance risk cards
Both clinical staff and patients were asked for their opinion
on the draft Substance Risk Cards. A Substance Risk Card
was created for each individual substance that was assessed
within the ASSIST screening tool. These cards serve the
purpose of outlining particular risks that are associated with
the use of specific substances. The use and purpose of the
Substance Risk Cards were the same as envisioned by the
WHO. However, in order to make them culturally and con-
textually appropriate, we made a number of changes based
on feedback from the FGs and interviews.Tailoring of substance risk impact
For example, health and psychosocial problems were
organised into separate categories of problems. An
attempt was made to weight the problems in the cat-
egories with the more problematic risks at the top. We
included how the particular substances might interact
with methadone and exacerbate problems for this cohort
in particular. The language on the Substance Risk Cards
was written in the first person. ‘Tick boxes’ were
included, as suggested by clinicians, so that during a
session with a patient the clinician could tick the box re-
lating to a set of risk factors that were pertinent to that
particular patient and therefore tailor the BI to the
patient based upon their individual risk profile. Photo-
graphs of key risks were included in order to display
risks pictorially for illiterate or semi-literate patients.
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[patients] about their liver risks or whatever but that
may not all sink in if you’ve a big long list like this it’s
very detailed, so maybe if you can break them into
categories with space …Tick the ones that are relevant
to them.
Modification and simplification of language
Participants in the FGs made suggestions for simplifying
the language and reordering the presentation of the risks
associated with particular illicit drugs and alcohol.
During the interviews with patients there were some
in vivo examples of patients not understanding some
terminology.
Frank, patient: What’s this one mean? Increased risk of
‘psychosis’, how do you mean? I don’t understand that
word.
Literacy concerns and pictorial solutions
Clinicians expressed concern that there may be too
much detail on the Substance Risk Cards and that
pictures should be considered to represent some of the
risk factors. This may also help with patients that have
literacy problems.
Paula, clinician: Pictures. Explanatory pictures. Just
thinking about literacy as Mary was saying earlier, like
the literacy sort of skills that individuals have might
be quite poor.
Imagery to underline risks
Patients also spoke about the potential use of powerful
imagery to underline the risks involved in drug use
behaviours.
Stephanie, patient: I think its good to shock people
about the reality of using drugs, the risks involved,
that would probably hit home. If there was an ad
where two people bought gear [heroin], and they went
to a flat, took it and then they feel asleep and one guy
wakes up and his friend is dead. Something like that
to kind of hit home. Like you need to include really
shocking pictures.
Interaction with methadone and importance of context
specific examples
A particular modification of the Substance Risk Card
was the inclusion of the interaction between methadone
and the target substance. This is a concern for this
cohort of patients in particular given that here may be
possible compromised liver function due to Hepatitis C
in patients on methadone treatment.Noel, clinician: That’s [alcohol and methadone
impact] important. I would put that interaction at the
top of the page. You really need to do that with all of
the substances.
Both patients and clinicians spoke about the import-
ance of context specific examples relating to the cohort
of methadone patients and suggested modifications to
the existing Substance Risk Card template. Clinicians in
the FGs questioned the hierarchy of problems that
patients are concerned with and suggested that patients
are less concerned with physical health risks but rather
psychosocial risks.
Mark, clinician: ‘High blood pressure’-they don’t really
care about that kind of stuff…whereas if you say, ‘a
relationship problem with your family’ then that
would have more meaning…I know the other stuff ’s
important but in their lives but there’ll be some things
that will be of more relevance to them than others. I
think psychosocial problems are very important. They
are the biggest problem.
Patients did however recognise physical risks as a
consequence of drug taking, such as dental damage and
a general detrimental effect of long-term drug use on
appearance.
Anita, patient: The dental damage, appearance and
all… Let people know, like you don’t realise how much
your appearance has gone down, yeah. My teeth are in
an awful state.
Criminal behaviour
A patient indicated that criminal behaviour is particu-
larly associated with this cohort, especially in relation to
intravenous drug users and that this risk needed to be
highlighted within the Substance Risk Cards.
Ronan, patient: I shoplift because it’s so easy. I just go
in and hold up a place with a shotgun. My sister
comes with me. She goes in, folds up the clothes and
puts them in a bag” …Nothing matters once you get
your fix into you. You don’t care about the
consequences.
Pros and Cons of substance use/reasons to quit or cut
down
The “Pros and Cons of Substance Use” element of a BI
is used by the clinician to help patients examine the rea-
sons for the use of the target substance in the first place
and to consider the reasons to quit or cut down on the
target substance. These are considered prompts for clini-
cians to draw from. The patient’s own suggestions and
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“Pros and Cons” section was used in the same manner
as outlined by the WHO. However, a number of changes
were made based on feedback from clinicians and
patients so as to make it contextually and culturally
appropriate to our cohort. For example, we provided a
lot more detail in the examples and also additional
categories were created such as ‘addiction; ‘crime’,
‘money’ that would be particularly salient to our cohort.Reasons for drinking alcohol or using illicit drugs
Patients gave their views on the drafted “Reasons for
Drinking or Using Drugs”, many of which resonated
with patients, as exemplified in the following extract:
Tina, patient: Reasons for drinking or using drugs.
[reads] “To get out of me head”, “to relax when I’m
stressed”; “to cope with feelings of boredom”. Yeah I
recognise myself in each of them. You don’t have the
word ‘despair’ in there do you? You should also put in
more about depression and loneliness.Reasons to quit or cut down from alcohol or illicit drugs
Some clinicians were quite critical of the drafted Rea-
sons to Quit or Cut Down from Alcohol or Illicit Drugs,
and made further suggestions for improvements.
Ruth, clinician: I don’t think the reasons for quitting or
cutting down are great-they’re too vague. “To live
longer and feel better”, I mean saying that to a 30 year
old would be a waste of time-[reads] “consume fewer
empty calories”, well that’s going to be of no interest
for men. [reads] “To sleep better”, many of them
[patients] may not even realise they’ve got sleep
problems. The dangers of alcohol and drugs are so
huge I just feel that list is not great… “to be a better
parent”, “have a more normal life”, I’d actually be
more straight forward and say “to prevent family
breakdown and children being taken into care”
because that’s actually something our cohort is
seriously hit with…so really just go for the jugular.
Financial Reasons to Quit or Cut Down also resonated
with patients.
Nigel, patient: Yeah, I think they’re all solid reasons to
quit or cut down. Definitely to have more money. Like
I mean as I was saying earlier I think I could probably
have [laughs] a property portfolio.
Two particular issues that are pertinent to this cohort
within Reasons to Quit or Cut Down their substance use
were criminal activity and subsequent court convictions.Stephanie, patient: If you have a charge or a
[criminal] record… and you’re on the drug courts,
some people will cut down, not because they want to
but because it’ll look good for the courts. And also they
want the kids back off the courts.
Take home materials
A discussion took place as to whether patients would
value any Take Home materials from the BI session.
It was proposed that Take Home materials would
include two tailored pieces of information resulting
from the BI; firstly, the Feedback Report Card with
results from the ASSIST screening tool that would
identify which of the substances that patients were
using was most harmful; and secondly, the Substance
Risk Card that would be personalised to the patient
which would have each individual risk item ticked
that was discussed during the BI. Discussion also took
place as to how these Take Home materials would be
presented to patients. There were mixed opinions
expressed as to whether patients would retain the
information from the BI that would be provided to
them. When asked as to whether Take Home
materials would be something that patients would
value, a participant replied:
Amy, patient: Do you know what an addict would do
with that? F**k it away when they get outside. No.
They’d just throw it away, they would.
However, some patients thought that the Take Home
materials would be of benefit, especially with a view to
retaining the documents for future reading.
Nigel, patient: I think if it was explained to me … if I
was reminded every 2 to 3 months to take this out and
have a look…, I suppose if it was in a little folder in
terms of presentation and I could put it off to one side
and come back to it every 2 to 3 months.
Confidentiality was a key concern of both clinicians
and patients with regard to how the Take Home
material would be given to the patients. An innocu-
ous folder with a neutral cover and title was
suggested and subsequently adopted. This would serve
the dual purpose of providing a reminder of the key
risks involved with the continued use of the target
substance, while also providing a generic folder that
patients would be comfortable holding.
Tina, patient: Put it in a folder. And I think it should
be private. … Like “Healthy Living” or “Healthy
Options”, do you know, something like that should be
printed on the front.
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The present paper describes the process of tailoring a BI
for use with opioid dependent methadone maintained
patients. The intervention and accompanying manual
was developed with feedback from clinicians and
patients. Changes were suggested by participants and
implemented if the majority of participants were in
agreement with the change, if it was in keeping with the
key components of BIs and if it was practical. Modifica-
tions included the ASSIST screening tool and BIs
outlined in one manual, the incorporation of a one page
step by step guide to a BI with timings and the 5A's
algorithm. Also the tailoring of the sample script to a
methadone maintained cohort, and the inclusion of
cohort specific examples such as criminal activity and
family breakdown within the Substance Risk Cards, use
of pictures to help semi-literate and illiterate patients,
and inclusion of interaction between particular
substances and methadone.
Tailoring the BI in this way served a number of vital
purposes. The manual was utilised in developing screen-
ing and BI training sessions that were delivered by an
expert trainer (author RA). Training sessions were
mapped directly onto the manual, which facilitated the
standardisation of training sessions across trial sites.
This allowed the research team to assess fidelity to the
intervention manual throughout the training sessions.
Treatment fidelity refers to the methodological strategies
used to monitor and enhance the reliability and validity
of behavioural interventions. Developing an intervention
manual is considered a key step in reducing unintended
variability in training sessions as outlined by the Behav-
ioral Change Consortium [44].
There were a number of additional gains to devoting
time during this pre-trial phase, such as increased stake-
holder involvement, which led to better clinician buy-in
for the trial itself. Ignoring the social context in which
interventions take place has been identified as a signifi-
cant barrier to translating evidence into on-going
practice [45]. It has been recognised that intervention
developers, the organisations in which the intervention
takes place and staff therein, play a crucial role in the
active implementation phase of an intervention [22].
This is known as the ‘ecological’ fit within the Quality
Implementation Framework and is recognised as a key
step in enhancing the intervention’s ‘fit’ to the clinical
environment [23]. During the intervention design we
also elicited feedback and input from a range of inter-
national experts in the area of BIs, which served to
improve the quality of the final intervention. This
allowed the intervention to retain the ‘core components’
of the original BI but allowed the researchers to adapt
the ‘periphery’ elements [24]. For example, a core com-
ponent of a BI is motivational interviewing, in whichsessions are patient centred and directed which encour-
ages the process of change by exploring ambivalence
and facilitating patients to implement change [6]. This
process was not altered in any way, as it is integral to a
BI. Within motivational interviewing quite typically the
Stages of Change ‘wheel’ can be presented to patients to
assist in the determination of where in the process of
change that individual patient sits [5]. We altered the
language of pre-contemplation, contemplation, prepar-
ation, action, maintenance and relapse to be more
understandable and in a plain English style to become
‘not thinking about it’, ‘thinking about it’, ‘getting ready’
‘doing’, ‘minding’ and ‘falling back’. This would have
maintained the core concept of the Stages but
transformed the language to be more accessible to a
population with low and in some cases no literacy. The
investment in time and resources to undertake this
qualitative process paid dividends for the subsequent
trial. The results of the cluster RCT have demonstrated
that a single clinician delivered BI can result in a reduc-
tion in substance use within a methadone maintained
opiate dependent cohort, and this effect is sustained at
3 month follow-up [46].
Strengths of this study included eliciting feedback
from both clinicians and patients and being faithful to
recent WHO recommendations [1, 47] and those of the
UK Medical Research Council when designing a
complex intervention [25]. The purposive sampling
techniques of stakeholder sampling and criterion sam-
pling were chosen to select the clinicians and the
patients respectively. Stakeholder sampling is particularly
useful in the context of evaluation research and policy
analysis. The findings reported here were based on
qualitative analysis of FGs and interviews with a small
number of participants. It is not the aim of qualitative
research to achieve a representative sample in terms of
either population or probability. Statistical representa-
tiveness is not a prime requirement, when the objective
is to elicit opinions and feedback during the design
phase of a complex intervention [36]. A potential limita-
tion of the focus groups with clinicians was the possibil-
ity of introducing bias where clinical hierarchies may
dominate the group discussion. However, the facilitators
of the focus groups (CD and LW) were mindful of this
and encouraged active participation of all staff members
present regardless of clinical discipline or seniority.
There is a strong identity within the opioid using com-
munity and the involvement of service users in this
study has resulted in that culture informing the changes
to the BI manual. The context within which persons
used drugs and attended treatment services also is
reflected in the periphery changes. Future research
should aim to establish whether the tailored BI gained
any added benefit beyond a generalised BI. Future
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fidelity of the delivery of a training session to the inter-
vention manual. There is also a need to determine
whether improvements in fidelity are made through the
use of a carefully constructed training manual.
Conclusions
There is a paucity of research that describes the process
of tailoring interventions. It was feasible and helpful to
use qualitative methods to identify necessary modifica-
tions to the BI that underpinned the subsequent trial.
This approach generated a large number of suggested
changes that were implemented ahead of commencing
the intervention. The research team was faithful to
WHO recommendations to tailor BI programmes that
are culturally and contextually appropriate to the treat-
ment cohort and clinical environment. Outcome data
from the cluster RCT have demonstrated that the
tailored intervention was effective [21].
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